Skip to content
  • Investors
  • Contact Us
ROMEGROMEG
  • Our Company
  • Our Products
  • Pipeline
  • Press
Blog

Patent Allowance

Posted on December 12, 2018February 11, 2019 by gotcha_admin
12
Dec

ROMEG has received its patent allowance.

Patent issued
FDA Approval for GLOPERBA
Recent Posts
  • ROMEG Therapeutics Secures Two Additional U.S. Patents
  • Avion Pharmaceuticals, LLC and ROMEG Therapeutics, LLC finalize partnership agreement to license and commercialize Gloperba, a prophylactic treatment of gout in adults
  • FDA Approval for GLOPERBA
  • Patent Allowance
  • Patent issued
  • Our Company
  • Investors
  • Contact Us

GET UPDATES & STAY CONNECTED

(781) 569-5866
© 2022 Romeg Therapeutics, LLC.
  • Terms of Use
  • Privacy Policy
  • Our Company
  • Our Products
  • Pipeline
  • Investors
  • Press
  • Contact Us